Climb Bio, Inc. (CLYM) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -14.38M | -15.63M | -12.14M | -11.15M | -15.43M | -5.52M | -7.55M | -667K | -1.82M | -947K | 3.49M | -7.96M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 6.84% | -183.19% | -60.68% | -1571.36% | -748.49% | -483% | -316.48% | 91.63% | 88.01% | 88.79% | 183.59% | 42.97% |
| Net Income | -13.72M | -17.52M | -12.89M | -8.67M | -20.78M | -8.42M | -8.89M | -54.89M | -1.7M | -3.64M | -3.97M | -5.22M |
| Depreciation & Amortization | 38K | 30K | 29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 3.98M | 1.01M | 2.02M | 1.66M | 2.92M | 512K | 465K | 1.2M | 656K | 777K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.38M | 584K | -468K | -484K | -606K | -435K | -268K | 51.73M | 53K | 71K | -671K | -850K |
| Working Capital Changes | -2.07M | 1.27M | -2.79M | -3.01M | 3.93M | 1.67M | -1.31M | 1.98M | -640K | 1.42M | 7.47M | -2.67M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.41M | 1.79M | -393K | 93K | 72K | 237K | -222K | -1.18M | 20K | -672K | -142K | 14K |
| Cash from Investing | -12.96M | 25.54M | 15.26M | 4.79M | -42.75M | -53.41M | -71.79M | -9.64M | 13.75M | 36.75M | 28.04M | -1.6M |
| Capital Expenditures | 0 | 0 | -109K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.64M | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -77K | 0 | 0 | 0 | -5M | 0 | 0 | 0 | 0 |
| Cash from Financing | 5K | -21K | 0 | 0 | 0 | 41K | 2.27M | 128.4M | 15K | 288K | 528K | 24K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 5K | -21K | 0 | 0 | 0 | 41K | 2.27M | 128.4M | 15K | 288K | 528K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24K |
| Net Change in Cash | -27.33M | 9.88M | 3.12M | -6.34M | -58.21M | -58.95M | -76.97M | 118.11M | 11.92M | 35.76M | 32.06M | -9.14M |
| Free Cash Flow | -14.38M | -15.63M | -12.25M | -11.22M | -15.43M | -5.52M | -7.55M | -667K | -1.82M | -947K | 3.49M | -7.96M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 6.84% | -183.19% | -62.12% | -1582.91% | -748.49% | -483% | -316.48% | 91.63% | 88.01% | 88.79% | 183.59% | 42.97% |
| FCF per Share | -0.21 | -0.23 | -0.18 | -0.17 | -0.23 | -0.09 | -0.11 | -0.02 | -0.07 | -0.03 | 0.13 | -0.30 |
| FCF Conversion (FCF/Net Income) | 1.05x | 0.89x | 0.94x | 1.29x | 0.74x | 0.66x | 0.85x | 0.01x | 1.07x | 0.26x | -0.88x | 1.53x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |